Patel Chem Specialities Ltd
Incorporated in 2008, Patel Chem Specialities Limited (PCSL) is engaged in the manufacturing and exporting of pharmaceutical excipients and specialty chemicals.[1]
- Market Cap ₹ 209 Cr.
- Current Price ₹ 84.0
- High / Low ₹ 121 / 75.1
- Stock P/E 18.2
- Book Value ₹ 37.4
- Dividend Yield 0.00 %
- ROCE 35.2 %
- ROE 38.5 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 39.4%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE SME IPO
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 42 | 60 | 69 | 82 | 105 | |
| 40 | 56 | 64 | 71 | 90 | |
| Operating Profit | 2 | 4 | 5 | 12 | 15 |
| OPM % | 6% | 7% | 8% | 14% | 15% |
| 0 | 0 | 0 | 0 | 0 | |
| Interest | 0 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 1 | 1 | 1 |
| Profit before tax | 2 | 4 | 4 | 10 | 14 |
| Tax % | 20% | 35% | 30% | 26% | 25% |
| 1 | 2 | 3 | 8 | 11 | |
| EPS in Rs | 5.91 | ||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 20% |
| TTM: | 28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 67% |
| TTM: | 38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 39% |
| Last Year: | 38% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 1 | 18 | 25 |
| Reserves | 6 | 8 | 11 | 19 | 18 | 68 |
| 6 | 8 | 12 | 15 | 15 | 20 | |
| 5 | 7 | 13 | 12 | 15 | 17 | |
| Total Liabilities | 18 | 23 | 37 | 47 | 65 | 130 |
| 6 | 10 | 14 | 14 | 14 | 20 | |
| CWIP | 0 | 0 | 0 | 2 | 12 | 18 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| 13 | 13 | 23 | 31 | 39 | 92 | |
| Total Assets | 18 | 23 | 37 | 47 | 65 | 130 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| -24 | 2 | 2 | 6 | 2 | |
| -1,978 | -4 | -3 | -6 | -7 | |
| 332 | 0 | 1 | 0 | 5 | |
| Net Cash Flow | -1,670 | -1 | -0 | 0 | 0 |
Ratios
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 56 | 58 | 79 | 68 | 73 |
| Inventory Days | 15 | 12 | 45 | 64 | 61 |
| Days Payable | 47 | 35 | 77 | 52 | 51 |
| Cash Conversion Cycle | 25 | 35 | 47 | 79 | 83 |
| Working Capital Days | -1 | 6 | 19 | 29 | 57 |
| ROCE % | 28% | 26% | 39% | 35% |
Documents
Announcements
-
Disclosure Under Regulation 7(1)&7(2) Of SEBI(Prohibition Of Insider Trading) Regulation, 2015.
2d - Devansh Bhupesh Patel bought 59,200 shares on BSE on 17/11/2025.
-
Correction Of Date In Corporate Announcement - Outcome Of Unaudited Financial Statements For The Half-Year Ended September?2025.
17 Nov - Board approved unaudited half-year results for Sept 30, 2025; correction: announcement date is Nov 14, 2025; RPT disclosed.
-
Statement Of Deviation And Variation For Half Year Ended September 2025
14 Nov - No deviation; IPO raised ₹58.80 crore; ₹42.53 crore unutilized as of 30 Sep 2025.
-
Financial Result For Half Year Ended 30/09/2025
14 Nov - Approved H1 FY26 unaudited results: Revenue ₹6,164.51L, PAT ₹612.92L; equity raised, cash ₹3,998.91L; related-party transactions disclosed.
-
Announcement Under Regulation 30 (LODR)- Change In Management
14 Nov - M/s Bimal Shah Associates appointed as internal auditor for FY2025-26, effective November 14, 2025.
Business Profile[1]
Patel Chem Specialities Limited is engaged in the manufacturing of cellulose-based excipients used primarily in the pharmaceuticals, food & beverages, cosmetics, and industrial sectors. These products act as binders, disintegrants, thickeners, stabilizers, and gelling agents across a variety of applications.